The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Cytokine-Related Aging Process
Open accessAbstract
CYTOKINES are soluble peptide messengers that are synthesized by lymphocytes (thus, they were originally called lymphokines), neutrophils, macrophages, and neuronal cells. The first experimental evidence that circulating factors could modulate the immune system was published in 1932 (1). It was not, however, until more than 30 years later that peptide mediators of lymphocyte activity were identified (2). Two years later, Gery and colleagues (3) isolated soluble peptide messengers from macrophages, and the concept of cytokines as “the great communicators” between immune and somatic cells in response to inflammation was born. Today, it is recognized that cytokines can be both proinflammatory and antiinflammatory and have a wide range of effects on organ systems throughout the body (Figure 1). Originally, each cytokine was named after the function it was recognized to perform. However, it soon was realized that cytokines produced multiple functions, and, thus, in 1979, a consensus committee decided to rename the cytokines “interleukins” followed by a number (4). Nonetheless, some cytokines have retained other names, for example, tumor necrosis factors (TNFs) (originally cachectins), interferons, and, most recently, the adipocyte-produced cytokines, or adipocytokines, such as adiponectin and leptin. Recently, there has been an increasing awareness that the cytokine response to nonspecific inflammation may be a component of the pathophysiology of frailty, functional decline, and death in older persons (5,6). Some cytokines, such as interleukin-10 (IL-10), are antiinflammatory and oppose the actions of the proinflammatory cytokines. Westendorp has suggested that the balance between proinflammatory and antiinflammatory cytokines favors either a long life or reproductive success (7). Thus, persons with high levels of tumor necrosis factor alpha (TNFα) and low levels of IL-10 will have few children but live a long time. This is the modern version of Thomas Kirkwood's “disposable soma” theory, which stated that investment in maintenance and repair comes at the expense of investment in reproduction. Tissue destruction or infection leads to a nonspecific acute-phase response. Markers of this nonspecific response are C-reactive protein (CRP) and serum amyloid protein, which increase rapidly (within 6 hours and peak within 48 hours) following an acute-phase stimulus. CRP derived its name from its ability to precipitate the C-polysaccharide of streptococcus pneumoniae (8). Both CRP and serum amyloid protein are members of the pentraxin family (Gk. penta = five; ragos = berries). When CRP binds to damaged cell membranes or lipids, it activates the classical complement pathway through C1q. CRP is increased after acute and chronic infection, in arthritic and other inflammatory disorders, tissue necrosis, neoplasia, cardiovascular disease, insulin resistance syndromes, obesity, smoking, stress, atrial fibrillation, oral estrogen intake, smoking, and coffee consumption (9). Liver disease, weight loss, exercise, moderate alcohol intake, and hepatic hydroxymethyl glutaryl coenzyme A (HMGCoA) reductase inhibitors are associated with lower CRP levels. Autoimmune diseases, such as systemic lupus erythematosus, fail to produce a CRP response. Thus, while CRP is a sensitive marker of disease processes, it is notoriously nonspecific. In older persons, CRP has been shown to be a marker of functional decline and mortality (10–13). Because of the nonspecificity of CRP, there has been a search for more specific markers that could explain the pathophysiology of functional deterioration with aging, sarcopenia, and the anorexia of aging (6,14–21). Interleukin-6 (IL-6) was one of the first cytokines to be linked to the aging process, and has been termed the “geriatric cytokine” (22). IL-6 is released from macrophages and T lymphocytes. Both TNFα and interleukin-1 beta (IL-1β) are potent releasers of IL-6. IL-6, on the other hand, once released, feeds back to down-regulate the release of TNFα and IL-1β giving it an antiinflammatory, as well as a proinflammatory role. Increased IL-6 leads to loss of muscle and bone mass, fever, activation of the hypothalamic-pituitary-adrenal axis, activation of the hepatic acute phase response, and hemodilution, resulting in a decline in hemoglobin levels (23–26). In bone, IL-6 is produced by osteoblasts and promotes osteoclast activity and subsequent bone resorption (27). Testosterone, which declines with aging in men (28,29), suppresses IL-6 production from bone (30). Parathyroid hormone levels, which increase with the age-associated decline in vitamin D (31), increase the production of IL-6 from osteoblasts (32). Parathyroid hormone also results in hepatic production of IL-6 and its soluble receptor (33). In older persons, elevated IL-6 levels have been shown cross-sectionally to be inversely associated with muscle mass and strength, physical performance, balance, and walking speed, and positively associate
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Predictors of skeletal muscle mass in elderly men and women
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00130-4 · Cited by 809
Self-citationCytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637
Review Article: Sarcopenia: Causes, Consequences, and Preventions
Marcell, T. J. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.10.m911 · Cited by 536
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
The Association of Plasma IL-6 Levels With Functional Disability in Community-Dwelling Elderly
Cohen, H. J., Pieper, C. F., Harris, T., Rao, K. M. K., & Currie, M. S. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.4.m201 · Cited by 476
Taaffe, D. R., Harris, T. B., Ferrucci, L., Rowe, J., & Seeman, T. E. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.12.m709 · Cited by 438
Cited by
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Self-citationPicon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
Cachexia: pathophysiology and clinical relevance1,2
Morley, J. E., Thomas, D. R., & Wilson, M.-M. G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.735 · Cited by 786
Self-citationFrailty: Toward a Clinical Definition
van Kan, G. A., Rolland, Y. M., Morley, J. E., & Vellas, B. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.11.005 · Cited by 723
Self-citationInterleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692
Metadata
- Authors
- Morley, J. E., & Baumgartner, R. N.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-01
- Volume
- 59
- Issue
- 9
- Pages
- M924-M929
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2148751064
- Cited by
- 188
- References
- 16
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokine-Related Aging Process. https://app.cochat.ai/papers/10.1093/gerona/59.9.m924
- The paper
- Morley, J. E., & Baumgartner, R. N. (2004). Cytokine-Related Aging Process. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/59.9.m924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.